This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Oxford University Innovation Ltd. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Headington, GB (2020)
- Oxford, GB (2022)
Company Filing History:
Years Active: 2020-2022
Title: Innovations of James R Larkin
Introduction
James R Larkin is a notable inventor based in Headington, GB. He has made significant contributions to the field of medical diagnostics, particularly in the area of brain tumor detection. With a total of 2 patents to his name, Larkin's work showcases his dedication to advancing healthcare technologies.
Latest Patents
Larkin's latest patents include "Methods and systems of multiphase arterial spin labeling," which focuses on systems and methods for multiphase pseudo-continuous arterial spin labeling. Another significant patent is titled "Method for diagnosing a brain tumour in a human." This invention outlines an in vitro method for diagnosing brain tumors by determining the concentration of metabolites in biofluid samples and comparing them to reference standards. The method aims to identify concentration differences that correlate with the presence of a brain tumor, thus providing a valuable diagnostic tool.
Career Highlights
James R Larkin is associated with Oxford University Innovation Ltd, where he applies his expertise in medical technology and innovation. His work has the potential to impact the way brain tumors are diagnosed and treated, contributing to improved patient outcomes.
Collaborations
Larkin has collaborated with notable colleagues such as Nicola Ruth Sibson and Martin Craig, enhancing the research and development of his innovative methods.
Conclusion
James R Larkin's contributions to medical diagnostics through his patents reflect his commitment to innovation in healthcare. His work not only advances scientific understanding but also holds promise for improving patient care in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
